A CD40 Agonist and PD-1 Antagonist Antibody Reprogram the Microenvironment of Nonimmunogenic Tumors to Allow T-cell–Mediated Anticancer Activity

Hayley S. Ma, Bibhav Poudel, Evanthia Roussos Torres, John William Sidhom, Tara M. Robinson, Brian Christmas, Blake Scott, Kayla Cruz, Skylar Woolman, Valerie Z. Wall, Todd Armstrong, Elizabeth M. Jaffee

Research output: Contribution to journal › Article › peer-review

37 Scopus citations

Fingerprint

Dive into the research topics of 'A CD40 Agonist and PD-1 Antagonist Antibody Reprogram the Microenvironment of Nonimmunogenic Tumors to Allow T-cell–Mediated Anticancer Activity'. Together they form a unique fingerprint.

Medicine & Life Sciences